Glycogen Storage Disease Type III

Known as: GDE DEFICIENCY, Glycogenosis 3s, LIMIT DEXTRINOSIS 
An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
AbstractGlycogen storage disease type III (GSD III) is a rare autosomal recessive inherited disorder caused by a deficiency of… (More)
  • figure 1
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Glycogen synthase kinase-3beta (GSK-3beta) has been postulated to mediate Alzheimer's disease tau hyperphosphorylation, beta… (More)
Is this relevant?
2000
2000
BACKGROUND Diabetes mellitus is a rare complication of glycogen storage disease type III (GSD III). CASE REPORT We describe a… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Glycogen synthase kinase-3 (GSK-3) is a serine/threonine protein kinase, the activity of which is inhibited by a… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Insulin resistance, a major factor in the pathogenesis of type 2 diabetes mellitus, is due mostly to decreased… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Growth factor-dependent survival of a variety of mammalian cells is dependent on the activation of phosphatidylinositol (PI) 3… (More)
Is this relevant?
1993
1993
To identify the severity of cardiac involvement in glycogen storage disease type III (GSDIII), and its relation to skeletal… (More)
  • table 1
  • figure 2
Is this relevant?
1992
1992
OBJECTIVE To determine whether a specific subtype of glycogen storage disease type III is associated with myopathy and… (More)
Is this relevant?
1989
1989
Twenty patients with enzymatically proven glycogen storage disease type III (GSD III) aged 3–30 years underwent cardiological… (More)
  • figure 1
  • figure 2
Is this relevant?
1986
1986
Sixteen patients with glycogen storage disease type III (GSD III) aged 3 to 22 years underwent a detailed neuromuscular… (More)
Is this relevant?